EMAIL THIS PAGE TO A FRIEND

ACS nano

Trans-blood brain barrier delivery of dopamine-loaded nanoparticles reverses functional deficits in parkinsonian rats.


PMID 25825926

Abstract

Sustained and safe delivery of dopamine across the blood brain barrier (BBB) is a major hurdle for successful therapy in Parkinson's disease (PD), a neurodegenerative disorder. Therefore, in the present study we designed neurotransmitter dopamine-loaded PLGA nanoparticles (DA NPs) to deliver dopamine to the brain. These nanoparticles slowly and constantly released dopamine, showed reduced clearance of dopamine in plasma, reduced quinone adduct formation, and decreased dopamine autoxidation. DA NPs were internalized in dopaminergic SH-SY5Y cells and dopaminergic neurons in the substantia nigra and striatum, regions affected in PD. Treatment with DA NPs did not cause reduction in cell viability and morphological deterioration in SH-SY5Y, as compared to bulk dopamine-treated cells, which showed reduced viability. Herein, we report that these NPs were able to cross the BBB and capillary endothelium in the striatum and substantia nigra in a 6-hydroxydopamine (6-OHDA)-induced rat model of PD. Systemic intravenous administration of DA NPs caused significantly increased levels of dopamine and its metabolites and reduced dopamine-D2 receptor supersensitivity in the striatum of parkinsonian rats. Further, DA NPs significantly recovered neurobehavioral abnormalities in 6-OHDA-induced parkinsonian rats. Dopamine delivered through NPs did not cause additional generation of ROS, dopaminergic neuron degeneration, and ultrastructural changes in the striatum and substantia nigra as compared to 6-OHDA-lesioned rats. Interestingly, dopamine delivery through nanoformulation neither caused alterations in the heart rate and blood pressure nor showed any abrupt pathological change in the brain and other peripheral organs. These results suggest that NPs delivered dopamine into the brain, reduced dopamine autoxidation-mediated toxicity, and ultimately reversed neurochemical and neurobehavioral deficits in parkinsonian rats.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB3500343
Anti-Bax antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
HPA027878
Anti-BAX antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4502549
Anti-BAX antibody produced in rabbit, affinity isolated antibody
B8429
Anti-Bax antibody, Mouse monoclonal, clone 6A7, purified from hybridoma cell culture
B8554
Anti-Bax antibody, Mouse monoclonal, clone 2D2, purified from hybridoma cell culture
SAB4502546
Anti-BAX, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4502547
Anti-BAX, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB1401089
Anti-CSF2RB antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB1410987
Anti-CYCS antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
C5723 Anti-Cytochrome c antibody produced in sheep, whole antiserum
C9616
Anti-Cytochrome c antibody produced in sheep, ~0.5 mg/mL, affinity isolated antibody, buffered aqueous solution
GW22756 Anti-Endoglin antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
E7534
Anti-Endoglin antibody produced in rabbit, ~1.0 mg/mL, affinity isolated antibody, buffered aqueous solution
AV33068
Anti-ENG (AB1) antibody produced in rabbit, IgG fraction of antiserum
HPA011862
Anti-ENG antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2101602
Anti-NKX3-1 (ab1) antibody produced in rabbit, affinity isolated antibody
SAB2101603
Anti-NKX3-1 (ab2) antibody produced in rabbit, affinity isolated antibody
SAB1412056
ANTI-NKX3-1 antibody produced in mouse, clone 3C1, purified immunoglobulin, buffered aqueous solution
AV43845
Anti-SLC18A2 antibody produced in rabbit, affinity isolated antibody, lyophilized powder
SAB2502027
Anti-SLC6A3 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
HPA013602
Anti-SLC6A3 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2501155
Anti-TH (C-terminal) antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2103892
Anti-TH, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB2103911
Anti-TH, (N-terminal) antibody produced in rabbit, affinity isolated antibody
T8700 Anti-Tyrosine Hydroxylase antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution, sufficient for 10 blots
V9014 Anti-VMAT2 antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
H1252
Homovanillic acid, Fluorimetric reagent
C9H10O4
B9054 Monoclonal Anti-Bax antibody produced in mouse, 2 mg/mL, clone 5B7, purified immunoglobulin, buffered aqueous solution
WH0000581M1
Monoclonal Anti-BAX antibody produced in mouse, clone 1F5-1B7, purified immunoglobulin, buffered aqueous solution
SAB4700258 Monoclonal Anti-CD105 antibody produced in mouse, clone MEM-226, purified immunoglobulin, buffered aqueous solution